Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Entera Bio Q2 EPS $(0.06), Inline, Sales $57.00K

Author: Benzinga Newsdesk | August 09, 2024 04:09pm

Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 62.5 percent increase over losses of $(0.16) per share from the same period last year. The company reported $57.00 thousand in sales this quarter.

Posted In: ENTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist